Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of granisetron on facial skin sensitivity in healthy volunteers
2013-000026-57Phase 2Completed
- Sponsor
- Karolinska Institutet
- Start
- May 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of granisetron, sponsored by Karolinska Institutet. Primary endpoint: Increase of sensory or pain thresholds. Started May 2013; status: completed.
02
Drugs
granisetron
Beyond the preview
Go deeper on 2013-000026-57.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-000026-57.